Cardiac Resynchronization Therapy Market: Size, Trends, and Strategic Growth Insights The cardiac resynchronization therapy (CRT) market is experiencing significant growth driven by advancements in cardiovascular health technologies and rising prevalence of heart failure globally. Increasing adoption of implantable devices and innovation in device functionalities align with emerging market trends and evolving industry dynamics. Below is a detailed market analysis covering size, investment, regional prospects, key players, and frequently asked questions grounded in 2024-2025 data. Market Size and Overview The cardiac resynchronization therapy (CRT) market is estimated to be valued at USD 7.94 billion in 2025 and is expected to reach USD 12.42 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. https://www.coherentmi.com/industry-reports/cardiac-resynchronization-therapy-market